Clinical Trials Logo

Recurrent or Refractory Solid Tumors clinical trials

View clinical trials related to Recurrent or Refractory Solid Tumors.

Filter by:
  • None
  • Page 1

NCT ID: NCT02013336 Recruiting - Neuroblastoma Clinical Trials

Phase 1 Study of MM-398 Plus Cyclophosphamide in Pediatric Solid Tumors

Start date: December 2013
Phase: Phase 1
Study type: Interventional

This is a Phase 1 study of the combination of two drugs: MM-398 and Cyclophosphamide. The goal is to find the highest dose of MM-398 that can be given safely when it is used together with the chemotherapy drug Cyclophosphamide.

NCT ID: NCT00756340 Completed - Clinical trials for Recurrent or Refractory Solid Tumors

A Trial of Everolimus and Bevacizumab in Children With Recurrent Solid Tumors

Start date: July 2008
Phase: Phase 1
Study type: Interventional

The main goals of this Phase I study are to learn about the side effects that may occur when everolimus and bevacizumab are given to children and young adults and to find the highest doses of these drugs that can be given together without causing severe side effects. Bevacizumab will be given into the vein (IV) over 30-90 minutes every two weeks and everolimus tablets will be given daily by mouth. A cycle of therapy will be four weeks.